| CAS ID: | 525-66-6 |
| Molecular Formula: | C16H21NO2 |
| Molecular Weight: | 259.4 g/mol |
| Monoisotopic Mass: | 259.1572 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RAPRANOL SR | PROPRANOLOL HYDROCHLORIDE | INDERAL LA | DUPROMEX | AVLOCARDYL | Inderide-80/25 | SLOPROLOL | SLO-BLOK | PROPANIX-40 | PROPANIX-160 | INNOPRAN XL | Inderal | PROPANIX LA | PROPRANOLOL | BEDRANOL S.R. | SLO-PRO | ANGILOL | APSOLOL | AY 64043 | HALF BETA-PROGRANE MR | HALF PROPANIX LA | HALF-BETADUR CR | PROPATARD LA | PROPRANOLOL HYDROCHLORIDE INTENSOL | INDERAL | BEDRANOL | HALF-BEPRANE CR | PROPANIX-160 SR | PROPANIX-80 | Inderide-40/25 | Tesnol | Sagittol | SYPROL | ICI 45520 | HALF-INDERAL LA | CARDINOL | PROPANIX-10 | PROBETA LA | INNOPRAN | HEMANGEOL | HALF PROPATARD LA | LOPRANOL LA | LEDERPRONOL | BETADUR CR | BETA-PROGRANE MR | BERKOLOL |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02484573 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Recruiting |
| First Received | June 29, 2015 | Last Verified | January 31, 2019 |
| Sponsor | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | ||
Trial Record 2
| ClinicalTrial ID | NCT00188045 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Terminated |
| First Received | September 16, 2005 | Last Verified | November 1, 2017 |
| Sponsor | University Hospital, Angers | ||
Trial Record 3
| ClinicalTrial ID | NCT01134692 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | June 2, 2010 | Last Verified | June 2, 2010 |
| Sponsor | Govind Ballabh Pant Hospital | ||
Trial Record 4
| ClinicalTrial ID | NCT00772057 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | October 15, 2008 | Last Verified | December 21, 2009 |
| Sponsor | Govind Ballabh Pant Hospital | ||
Trial Record 5
| ClinicalTrial ID | NCT00332904 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | June 2, 2006 | Last Verified | June 4, 2010 |
| Sponsor | Hvidovre University Hospital | ||
Trial Record 6
| ClinicalTrial ID | NCT02923336 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Recruiting |
| First Received | October 4, 2016 | Last Verified | January 31, 2019 |
| Sponsor | ALDO TORRE DELGADILLO | ||
Trial Record 7
| ClinicalTrial ID | NCT01370161 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | June 9, 2011 | Last Verified | January 17, 2019 |
| Sponsor | Fourth Military Medical University | ||
Trial Record 8
| ClinicalTrial ID | NCT00965900 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Recruiting |
| First Received | August 26, 2009 | Last Verified | August 23, 2017 |
| Sponsor | Korea University | ||
Trial Record 9
| ClinicalTrial ID | NCT02385422 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | March 11, 2015 | Last Verified | March 11, 2015 |
| Sponsor | Shanghai Zhongshan Hospital | ||
Trial Record 10
| ClinicalTrial ID | NCT01897051 | Disease | Liver fibrosis |
| Phase | Phase 2,Phase 3 | Status | Unknown |
| First Received | July 11, 2013 | Last Verified | April 21, 2015 |
| Sponsor | Yonsei University | ||
Trial Record 11
| ClinicalTrial ID | NCT02012777 | Disease | Fibrosis |
| Phase | Phase 1 | Status | Terminated |
| First Received | December 16, 2013 | Last Verified | June 8, 2017 |
| Sponsor | University of Miami | ||